Potentiating NK cell activity by combination of Rosuvastatin and Difluoromethylornithine for effective chemopreventive efficacy against Colon Cancer.

Sci Rep · 2016 · PMC5107958 · PMID 27841323

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Though inhibition of colon adenocarcinoma incidence by 20.7% (p = 0.052) was observed in low dose dietary administration of DFMO compared to control diet fed rats, it did not reach statistical significance ( Fig. 2B ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.